lunes, 15 de octubre de 2018

Synspira's SNSP113 Gets Orphan Status to Treat Bacterial Infection in CF

Synspira's SNSP113 Gets Orphan Status to Treat Bacterial Infection in CF

Cystic Fibrosis News Today

Synspira’s Candidate SNSP113 Wins FDA Orphan Designation to Treat Bacterial Infections in Cystic Fibrosis

 OCTOBER 15, 2018
Patricia Inacio, PhDBY PATRICIA INACIO, PHD
 
IN CYSTIC FIBROSIS.
Synspira’s Candidate SNSP113 Wins FDA Orphan Designation to Treat Bacterial Infections in Cystic Fibrosis
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)